Lixin Pharmaceutical is a professional manufacturer of APIs, pharmaceutical excipients and advanced intermediates that integrates R&D, production and sales, and has passed GMP certification in the United States, the European Union and China. The company adheres to the path of independent R&D and independent innovation, and aims to meet the requirements of regulated API markets at home and abroad. It has built multiple GMP workshops and chemical synthesis workshops as well as complete supporting public and auxiliary facilities, and has established a standardized quality management system and an advanced quality control system. It conducts business with a number of domestic and foreign pharmaceutical companies, providing high-quality APIs and key intermediates.
On the basis of the cGMP API production base in Suzhou High-tech Zone, Lixin Pharmaceutical has invested in the Shandong Lixin Pharmaceutical project. The Shandong Lixin Pharmaceutical high-end specialty APIs and preparations project is a key project of Zibo City, one of the first batch of preferred projects of major projects for the conversion of new and old kinetic energy in Shandong Province, and a key project of national strategic emerging industries.
Now:
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows